These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17328269)

  • 41. Validation of a noninvasive test routinely used in otology for the diagnosis of cerebrospinal fluid shunt malfunction in patients with normal pressure hydrocephalus.
    Sakka L; Chomicki A; Gabrillargues J; Khalil T; Chazal J; Avan P
    J Neurosurg; 2016 Feb; 124(2):342-9. PubMed ID: 26295913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experience with the Strata valve in the management of shunt overdrainage.
    Kondageski C; Thompson D; Reynolds M; Hayward RD
    J Neurosurg; 2007 Feb; 106(2 Suppl):95-102. PubMed ID: 17330533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shunt assistant valve: bench test investigations and clinical performance.
    Tokoro K; Suzuki S; Chiba Y; Tsuda M
    Childs Nerv Syst; 2002 Oct; 18(9-10):492-9. PubMed ID: 12382174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The vanishing shunt valve.
    Joshi KC; Khanapure K; Jagannatha AT; Varma RG
    Childs Nerv Syst; 2015 Nov; 31(11):2207-9. PubMed ID: 26099231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breakage of shunt devices (Sophy programmable pressure valve) following implantation in the hypochondriac region.
    Aihara N; Takagi T; Hashimoto N; Fukushima T; Karasawa K; Fuse T
    Childs Nerv Syst; 1997; 13(11-12):636-8. PubMed ID: 9454985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prosepective Study to Evaluate Rate and Frequency of Perturbations of Implanted Programmable Hakim Codman Valve After 1.5-Tesla Magnetic Resonance Imaging.
    Capitanio JF; Venier A; Mazzeo LA; Barzaghi LR; Acerno S; Mortini P
    World Neurosurg; 2016 Apr; 88():297-299. PubMed ID: 26455768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ventriculoperitoneal shunt infection and malfunction in adult patients: incidence, risk factors, and long-term follow-up of single institution experience.
    Kim M; Choi JH; Park JC; Ahn JS; Kwun BD; Park W
    Neurosurg Rev; 2024 Jun; 47(1):269. PubMed ID: 38864925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vitro experiment for verification of the tandem shunt valve system: a novel method for treating hydrocephalus by flexibly controlling cerebrospinal fluid flow and intracranial pressure.
    Aihara Y; Shoji I; Okada Y
    J Neurosurg Pediatr; 2013 Jan; 11(1):43-7. PubMed ID: 23140212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Withdrawal of shunt systems--clinical use of the programmable shunt system and its effect on hydrocephalus in children.
    Takahashi Y
    Childs Nerv Syst; 2001 Aug; 17(8):472-7. PubMed ID: 11508536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Shunt Overdrainage Caused by Displacement of the Pressure Control Cam after Pressure Adjustment.
    Kim SH; Lee YS; Lee MS; Suh SJ; Lee JH; Kang DG
    Korean J Neurotrauma; 2016 Oct; 12(2):163-166. PubMed ID: 27857929
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of Codman microcerebrospinal fluid shunt.
    Sandvig A; Arnell K; Malm J; Eklund A; Koskinen LD
    Brain Behav; 2018 Oct; 8(10):e01002. PubMed ID: 30207083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A clinical survey of hydrocephalus and current treatment for hydrocephalus in Japan: analysis by nationwide questionnaire.
    Miyake H; Ohta T; Kajimoto Y; Ogawa D
    Childs Nerv Syst; 1999 Aug; 15(8):363-8. PubMed ID: 10447603
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of transcranial real-time ultrasonography for programming a shunt valve system.
    Mursch K; Behnke J; Christen HJ; Markakis E
    Childs Nerv Syst; 1996 Jul; 12(7):392-5. PubMed ID: 8869775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved outcome in shunted iNPH with a combination of a Codman Hakim programmable valve and an Aesculap-Miethke ShuntAssistant.
    Lemcke J; Meier U
    Cent Eur Neurosurg; 2010 Aug; 71(3):113-6. PubMed ID: 20373276
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Programmable shunts and headphones: Are they safe together?
    Spader HS; Ratanaprasatporn L; Morrison JF; Grossberg JA; Cosgrove GR
    J Neurosurg Pediatr; 2015 Oct; 16(4):402-5. PubMed ID: 26149436
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Significance of hydrostatic valves in therapy of chronic hydrocephalus].
    Kiefer M; Eymann R; Mascarós V; Walter M; Steudel WI
    Nervenarzt; 2000 Dec; 71(12):975-86. PubMed ID: 11139994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Strata NSC and Codman Hakim adjustable cerebrospinal fluid shunts and their corresponding antisiphon devices.
    Arnell K; Koskinen LO; Malm J; Eklund A
    J Neurosurg Pediatr; 2009 Mar; 3(3):166-72. PubMed ID: 19338461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Spontaneous rotation of programmable pressure valve in the chest wall: report of 3 cases].
    Sumioka S; Yasuda A; Nagasawa S; Ohta T; Shimizu K
    No Shinkei Geka; 1993 Jun; 21(6):557-60. PubMed ID: 8336814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of ventriculoperitoneal shunt valve design in the treatment of pediatric hydrocephalus--a single center study of valve performance in the clinical setting.
    Beez T; Sarikaya-Seiwert S; Bellstädt L; Mühmer M; Steiger HJ
    Childs Nerv Syst; 2014 Feb; 30(2):293-7. PubMed ID: 23900632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of magnetic fields from home-use magnetic induction therapy apparatuses on adjustable cerebrospinal fluid shunt valves].
    Nakashima K; Oishi A; Itokawa H; Fujimoto M
    No Shinkei Geka; 2010 Aug; 38(8):725-9. PubMed ID: 20697146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.